FibroBiologics announces new U.S. patent for fibroblast wound healing
FibroBiologics (FBLG) announced issuance of a new U.S. patent covering therapeutic use of fibroblasts in wound healing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.